Use of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeutics.

ABSTRACT:

SUBMITTER: Wong AK 

PROVIDER: S-EPMC10472182 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature